Restenosis after Coronary and Peripheral Intervention: Efficacy and Clinical Impact of Cilostazol.
Sign Up to like & getrecommendations! Published in 2017 at "Annals of vascular surgery"
DOI: 10.1016/j.avsg.2016.08.050
Abstract: Restenosis is one of the main complications in patients undergoing coronary or peripheral revascularization procedures and is the leading cause for their long-term failures. Cilostazol is the only pharmacotherapy that showed an adequate efficacy for… read more here.
Keywords: intervention efficacy; restenosis coronary; peripheral intervention; coronary peripheral ... See more keywords
Hypersensitivity and in-stent restenosis in coronary stent materials
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Bioengineering and Biotechnology"
DOI: 10.3389/fbioe.2022.1003322
Abstract: Coronary heart disease (CHD) is a type of cardiovascular disease with the highest mortality rate worldwide. Percutaneous transluminal coronary intervention (PCI) is the most effective method for treating CHD. However, in-stent restenosis (ISR), a long-term… read more here.
Keywords: coronary stent; restenosis coronary; hypersensitivity stent; hypersensitivity ... See more keywords